ID   BIP_HUMAN               Reviewed;         654 AA.
AC   P11021; B0QZ61; Q2EF78; Q9NPF1; Q9UK02;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   11-JUL-2001, sequence version 2.
DT   28-JAN-2026, entry version 259.
DE   RecName: Full=Endoplasmic reticulum chaperone BiP {ECO:0000305};
DE            EC=3.6.4.10 {ECO:0000269|PubMed:26655470};
DE   AltName: Full=78 kDa glucose-regulated protein {ECO:0000303|PubMed:2840249};
DE            Short=GRP-78 {ECO:0000303|PubMed:2840249};
DE   AltName: Full=Binding-immunoglobulin protein {ECO:0000303|Ref.4};
DE            Short=BiP {ECO:0000303|Ref.4};
DE   AltName: Full=Heat shock protein 70 family protein 5 {ECO:0000305};
DE            Short=HSP70 family protein 5 {ECO:0000305};
DE   AltName: Full=Heat shock protein family A member 5 {ECO:0000312|HGNC:HGNC:5238};
DE   AltName: Full=Immunoglobulin heavy chain-binding protein {ECO:0000303|Ref.4};
DE   Flags: Precursor;
GN   Name=HSPA5 {ECO:0000312|HGNC:HGNC:5238};
GN   Synonyms=GRP78 {ECO:0000303|PubMed:2840249};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2840249; DOI=10.1089/dna.1988.7.275;
RA   Ting J., Lee A.S.;
RT   "Human gene encoding the 78,000-dalton glucose-regulated protein and its
RT   pseudogene: structure, conservation, and regulation.";
RL   DNA 7:275-286(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Cervix carcinoma;
RA   Chao C.C.K.;
RL   Submitted (DEC-1995) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fibroblast;
RA   Hansen J.J., Nielsen M.N., Jorgensen M.M., Gregersen N., Bolund L.;
RT   "Grp78 is involved in the quality control of the LDL-receptor.";
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Bermudez-Fajardo A., Llewellyn D.H., Campbell A.K., Errington R.R.;
RT   "Sequence differences between human grp78/BiP isolated from HeLa cells and
RT   previously reported human sequences.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT HIS-543.
RG   NIEHS SNPs program;
RL   Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-25.
RX   PubMed=1480470; DOI=10.1093/nar/20.24.6481;
RA   Chao C.C.K., Lin-Chao S.;
RT   "A direct-repeat sequence of the human BiP gene is required for A23187-
RT   mediated inducibility and an inducible nuclear factor binding.";
RL   Nucleic Acids Res. 20:6481-6485(1992).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 20-650, AND DISEASE.
RC   TISSUE=Articular cartilage;
RX   PubMed=11160188; DOI=10.4049/jimmunol.166.3.1492;
RA   Corrigall V.M., Bodman-Smith M.D., Fife M.S., Canas B., Myers L.K.,
RA   Wooley P., Soh C., Staines N.A., Pappin D.J.C., Berlo S.E., van Eden W.,
RA   van Der Zee R., Lanchbury J.S., Panayi G.S.;
RT   "The human endoplasmic reticulum molecular chaperone BiP is an autoantigen
RT   for rheumatoid arthritis and prevents the induction of experimental
RT   arthritis.";
RL   J. Immunol. 166:1492-1498(2001).
RN   [11]
RP   PROTEIN SEQUENCE OF 22-38.
RC   TISSUE=Mammary carcinoma;
RX   PubMed=9150946; DOI=10.1002/elps.1150180342;
RA   Rasmussen R.K., Ji H., Eddes J.S., Moritz R.L., Reid G.E., Simpson R.J.,
RA   Dorow D.S.;
RT   "Two-dimensional electrophoretic analysis of human breast carcinoma
RT   proteins: mapping of proteins that bind to the SH3 domain of mixed lineage
RT   kinase MLK2.";
RL   Electrophoresis 18:588-598(1997).
RN   [12]
RP   PROTEIN SEQUENCE OF 19-39, AND FUNCTION.
RX   PubMed=2294010; DOI=10.1210/endo-126-1-672;
RA   Dana R.C., Welch W.J., Deftos L.J.;
RT   "Heat shock proteins bind calcitonin.";
RL   Endocrinology 126:672-674(1990).
RN   [13]
RP   PROTEIN SEQUENCE OF 19-40.
RC   TISSUE=Colon carcinoma;
RX   PubMed=9150948; DOI=10.1002/elps.1150180344;
RA   Ji H., Reid G.E., Moritz R.L., Eddes J.S., Burgess A.W., Simpson R.J.;
RT   "A two-dimensional gel database of human colon carcinoma proteins.";
RL   Electrophoresis 18:605-613(1997).
RN   [14]
RP   PROTEIN SEQUENCE OF 61-74; 82-96; 102-113; 124-152; 164-181; 186-214;
RP   307-336; 353-367; 448-464; 475-492; 563-573; 602-617 AND 622-654, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [15]
RP   FUNCTION.
RX   PubMed=1550958; DOI=10.1091/mbc.3.2.143;
RA   Ng D.T., Watowich S.S., Lamb R.A.;
RT   "Analysis in vivo of GRP78-BiP/substrate interactions and their role in
RT   induction of the GRP78-BiP gene.";
RL   Mol. Biol. Cell 3:143-155(1992).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH EIF2AK3.
RX   PubMed=11907036; DOI=10.1074/jbc.m200903200;
RA   Ma K., Vattem K.M., Wek R.C.;
RT   "Dimerization and release of molecular chaperone inhibition facilitate
RT   activation of eukaryotic initiation factor-2 kinase in response to
RT   endoplasmic reticulum stress.";
RL   J. Biol. Chem. 277:18728-18735(2002).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-518, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   INTERACTION WITH CCDC88B, SUBCELLULAR LOCATION, AND INDUCTION BY ER STRESS.
RX   PubMed=21289099; DOI=10.1091/mbc.e10-08-0724;
RA   Matsushita E., Asai N., Enomoto A., Kawamoto Y., Kato T., Mii S., Maeda K.,
RA   Shibata R., Hattori S., Hagikura M., Takahashi K., Sokabe M., Murakumo Y.,
RA   Murohara T., Takahashi M.;
RT   "Protective role of Gipie, a Girdin family protein, in endoplasmic
RT   reticulum stress responses in endothelial cells.";
RL   Mol. Biol. Cell 22:736-747(2011).
RN   [20]
RP   PROTEIN SEQUENCE OF 582-596, INTERACTION WITH METTL23, METHYLATION AT
RP   LYS-585, MUTAGENESIS OF LYS-585, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=23349634; DOI=10.1371/journal.pgen.1003210;
RA   Cloutier P., Lavallee-Adam M., Faubert D., Blanchette M., Coulombe B.;
RT   "A newly uncovered group of distantly related lysine methyltransferases
RT   preferentially interact with molecular chaperones to regulate their
RT   activity.";
RL   PLoS Genet. 9:E1003210-E1003210(2013).
RN   [21]
RP   COMPONENT OF A CHAPERONE COMPLEX.
RX   PubMed=12475965; DOI=10.1091/mbc.e02-05-0311;
RA   Meunier L., Usherwood Y.-K., Chung K.T., Hendershot L.M.;
RT   "A subset of chaperones and folding enzymes form multiprotein complexes in
RT   endoplasmic reticulum to bind nascent proteins.";
RL   Mol. Biol. Cell 13:4456-4469(2002).
RN   [22]
RP   INTERACTION WITH TRIM21.
RX   PubMed=12699405; DOI=10.1046/j.1365-2249.2003.02153.x;
RA   Purcell A.W., Todd A., Kinoshita G., Lynch T.A., Keech C.L., Gething M.J.,
RA   Gordon T.P.;
RT   "Association of stress proteins with autoantigens: a possible mechanism for
RT   triggering autoimmunity?";
RL   Clin. Exp. Immunol. 132:193-200(2003).
RN   [23]
RP   INTERACTION WITH DNAJC10.
RX   PubMed=12411443; DOI=10.1074/jbc.m206995200;
RA   Cunnea P.M., Miranda-Vizuete A., Bertoli G., Simmen T., Damdimopoulos A.E.,
RA   Hermann S., Leinonen S., Huikko M.P., Gustafsson J.-A., Sitia R.,
RA   Spyrou G.;
RT   "ERdj5, an endoplasmic reticulum (ER)-resident protein containing DnaJ and
RT   thioredoxin domains, is expressed in secretory cells or following ER
RT   stress.";
RL   J. Biol. Chem. 278:1059-1066(2003).
RN   [24]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=12643545; DOI=10.1021/pr025562r;
RA   Basrur V., Yang F., Kushimoto T., Higashimoto Y., Yasumoto K., Valencia J.,
RA   Muller J., Vieira W.D., Watabe H., Shabanowitz J., Hearing V.J., Hunt D.F.,
RA   Appella E.;
RT   "Proteomic analysis of early melanosomes: identification of novel
RT   melanosomal proteins.";
RL   J. Proteome Res. 2:69-79(2003).
RN   [25]
RP   FUNCTION (MICROBIAL INFECTION), AND SUBCELLULAR LOCATION.
RX   PubMed=15098107; DOI=10.1007/s00705-003-0263-x;
RA   Jindadamrongwech S., Thepparit C., Smith D.R.;
RT   "Identification of GRP 78 (BiP) as a liver cell expressed receptor element
RT   for dengue virus serotype 2.";
RL   Arch. Virol. 149:915-927(2004).
RN   [26]
RP   INTERACTION WITH CLN3.
RX   PubMed=18621045; DOI=10.1016/j.yexcr.2008.06.016;
RA   Uusi-Rauva K., Luiro K., Tanhuanpaeae K., Kopra O., Martin-Vasallo P.,
RA   Kyttaelae A., Jalanko A.;
RT   "Novel interactions of CLN3 protein link Batten disease to dysregulation of
RT   fodrin-Na+, K+ ATPase complex.";
RL   Exp. Cell Res. 314:2895-2905(2008).
RN   [27]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H., Mangini N.J.,
RA   Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R., Yamagishi S.,
RA   Shabanowitz J., Hearing V.J., Wu C., Appella E., Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [28]
RP   INTERACTION WITH ERLEC1; OS9; SEL1L AND SYVN1.
RX   PubMed=18502753; DOI=10.1074/jbc.m709336200;
RA   Hosokawa N., Wada I., Nagasawa K., Moriyama T., Okawa K., Nagata K.;
RT   "Human XTP3-B forms an endoplasmic reticulum quality control scaffold with
RT   the HRD1-SEL1L ubiquitin ligase complex and BiP.";
RL   J. Biol. Chem. 283:20914-20924(2008).
RN   [29]
RP   INTERACTION WITH ERLEC1; OS9; SEL1L AND SYVN1.
RX   PubMed=18264092; DOI=10.1038/ncb1689;
RA   Christianson J.C., Shaler T.A., Tyler R.E., Kopito R.R.;
RT   "OS-9 and GRP94 deliver mutant alpha1-antitrypsin to the Hrd1-SEL1L
RT   ubiquitin ligase complex for ERAD.";
RL   Nat. Cell Biol. 10:272-282(2008).
RN   [30]
RP   FUNCTION.
RX   PubMed=19538957; DOI=10.1016/j.yexcr.2009.06.009;
RA   Oikawa D., Kimata Y., Kohno K., Iwawaki T.;
RT   "Activation of mammalian IRE1alpha upon ER stress depends on dissociation
RT   of BiP rather than on direct interaction with unfolded proteins.";
RL   Exp. Cell Res. 315:2496-2504(2009).
RN   [31]
RP   FUNCTION (MICROBIAL INFECTION), SUBCELLULAR LOCATION, INDUCTION, AND
RP   BIOTECHNOLOGY.
RX   PubMed=20484814; DOI=10.1172/jci42164;
RA   Liu M., Spellberg B., Phan Q.T., Fu Y., Fu Y., Lee A.S., Edwards J.E. Jr.,
RA   Filler S.G., Ibrahim A.S.;
RT   "The endothelial cell receptor GRP78 is required for mucormycosis
RT   pathogenesis in diabetic mice.";
RL   J. Clin. Invest. 120:1914-1924(2010).
RN   [32]
RP   INTERACTION WITH PCSK4, AND SUBCELLULAR LOCATION.
RX   PubMed=21080038; DOI=10.1007/s11010-010-0635-y;
RA   Gyamera-Acheampong C., Sirois F., Denis N.J., Mishra P., Figeys D.,
RA   Basak A., Mbikay M.;
RT   "The precursor to the germ cell-specific PCSK4 proteinase is inefficiently
RT   activated in transfected somatic cells: evidence of interaction with the
RT   BiP chaperone.";
RL   Mol. Cell. Biochem. 348:43-52(2011).
RN   [33]
RP   INTERACTION WITH MANF.
RX   PubMed=22637475; DOI=10.1074/jbc.m112.356345;
RA   Glembotski C.C., Thuerauf D.J., Huang C., Vekich J.A., Gottlieb R.A.,
RA   Doroudgar S.;
RT   "Mesencephalic astrocyte-derived neurotrophic factor protects the heart
RT   from ischemic damage and is selectively secreted upon sarco/endoplasmic
RT   reticulum calcium depletion.";
RL   J. Biol. Chem. 287:25893-25904(2012).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S., Fischer-Posovszky P.,
RA   Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [35]
RP   METHYLATION AT LYS-585, AND MUTAGENESIS OF LYS-585.
RX   PubMed=23921388; DOI=10.1074/jbc.m113.483248;
RA   Jakobsson M.E., Moen A., Bousset L., Egge-Jacobsen W., Kernstock S.,
RA   Melki R., Falnes P.O.;
RT   "Identification and characterization of a novel human methyltransferase
RT   modulating Hsp70 function through lysine methylation.";
RL   J. Biol. Chem. 288:27752-27763(2013).
RN   [36]
RP   FUNCTION, INTERACTION WITH CEMIP, AND SUBCELLULAR LOCATION.
RX   PubMed=23990668; DOI=10.1093/jnci/djt224;
RA   Evensen N.A., Kuscu C., Nguyen H.L., Zarrabi K., Dufour A., Kadam P.,
RA   Hu Y.J., Pulkoski-Gross A., Bahou W.F., Zucker S., Cao J.;
RT   "Unraveling the role of KIAA1199, a novel endoplasmic reticulum protein, in
RT   cancer cell migration.";
RL   J. Natl. Cancer Inst. 105:1402-1416(2013).
RN   [37]
RP   FUNCTION, AND INTERACTION WITH DNAJC10.
RX   PubMed=23769672; DOI=10.1016/j.molcel.2013.05.014;
RA   Oka O.B., Pringle M.A., Schopp I.M., Braakman I., Bulleid N.J.;
RT   "ERdj5 is the ER reductase that catalyzes the removal of non-native
RT   disulfides and correct folding of the LDL receptor.";
RL   Mol. Cell 50:793-804(2013).
RN   [38]
RP   INTERACTION WITH CLU, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=22689054; DOI=10.1038/onc.2012.212;
RA   Li N., Zoubeidi A., Beraldi E., Gleave M.E.;
RT   "GRP78 regulates clusterin stability, retrotranslocation and mitochondrial
RT   localization under ER stress in prostate cancer.";
RL   Oncogene 32:1933-1942(2013).
RN   [39]
RP   FUNCTION (MICROBIAL INFECTION), INTERACTION WITH R.DELEMAR COTH2 AND COTH3
RP   (MICROBIAL INFECTION), AND SUBCELLULAR LOCATION.
RX   PubMed=24355926; DOI=10.1172/jci71349;
RA   Gebremariam T., Liu M., Luo G., Bruno V., Phan Q.T., Waring A.J.,
RA   Edwards J.E. Jr., Filler S.G., Yeaman M.R., Ibrahim A.S.;
RT   "CotH3 mediates fungal invasion of host cells during mucormycosis.";
RL   J. Clin. Invest. 124:237-250(2014).
RN   [40]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-518, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [41]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT LYS-585 AND LYS-591, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [42]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-352, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [43]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-352 AND LYS-353, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [44]
RP   FUNCTION, INTERACTION WITH CASP7 AND ELAPOR1, AND REGION.
RX   PubMed=26045166; DOI=10.1158/0008-5472.can-14-3751;
RA   Kang J.M., Park S., Kim S.J., Kim H., Lee B., Kim J., Park J., Kim S.T.,
RA   Yang H.K., Kim W.H., Kim S.J.;
RT   "KIAA1324 Suppresses Gastric Cancer Progression by Inhibiting the
RT   Oncoprotein GRP78.";
RL   Cancer Res. 75:3087-3097(2015).
RN   [45]
RP   AMPYLATION.
RX   PubMed=25601083; DOI=10.1074/jbc.m114.618348;
RA   Sanyal A., Chen A.J., Nakayasu E.S., Lazar C.S., Zbornik E.A., Worby C.A.,
RA   Koller A., Mattoo S.;
RT   "A novel link between Fic (filamentation induced by cAMP)-mediated
RT   adenylylation/AMPylation and the unfolded protein response.";
RL   J. Biol. Chem. 290:8482-8499(2015).
RN   [46]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-352, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [47]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [48]
RP   INTERACTION WITH CIPC.
RX   PubMed=26657846; DOI=10.1016/j.bbrc.2015.11.117;
RA   Matsunaga R., Nishino T., Yokoyama A., Nakashima A., Kikkawa U.,
RA   Konishi H.;
RT   "Versatile function of the circadian protein CIPC as a regulator of Erk
RT   activation.";
RL   Biochem. Biophys. Res. Commun. 469:377-383(2016).
RN   [49]
RP   INTERACTION WITH INPP5K.
RX   PubMed=26940976; DOI=10.1111/gtc.12353;
RA   Ijuin T., Hatano N., Takenawa T.;
RT   "Glucose-regulated protein 78 (GRP78) binds directly to PIP3 phosphatase
RT   SKIP and determines its localization.";
RL   Genes Cells 21:457-465(2016).
RN   [50]
RP   SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=27159390; DOI=10.1172/jci82744;
RA   Gebremariam T., Lin L., Liu M., Kontoyiannis D.P., French S.,
RA   Edwards J.E. Jr., Filler S.G., Ibrahim A.S.;
RT   "Bicarbonate correction of ketoacidosis alters host-pathogen interactions
RT   and alleviates mucormycosis.";
RL   J. Clin. Invest. 126:2280-2294(2016).
RN   [51]
RP   REVIEW.
RX   PubMed=28286085; DOI=10.1016/j.gene.2017.03.005;
RA   Wang J., Lee J., Liem D., Ping P.;
RT   "HSPA5 Gene encoding Hsp70 chaperone BiP in the endoplasmic reticulum.";
RL   Gene 618:14-23(2017).
RN   [52]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-352, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [53]
RP   FUNCTION, INTERACTION WITH LOXL2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=28332555; DOI=10.1038/srep44988;
RA   Cuevas E.P., Eraso P., Mazon M.J., Santos V., Moreno-Bueno G., Cano A.,
RA   Portillo F.;
RT   "LOXL2 drives epithelial-mesenchymal transition via activation of IRE1-XBP1
RT   signalling pathway.";
RL   Sci. Rep. 7:44988-44988(2017).
RN   [54]
RP   FUNCTION (MICROBIAL INFECTION), INTERACTION WITH JAPANESE ENCEPHALITIS
RP   VIRUS ENVELOPE PROTEIN E (MICROBIAL INFECTION), AND SUBCELLULAR LOCATION.
RX   PubMed=28053106; DOI=10.1128/jvi.02274-16;
RA   Nain M., Mukherjee S., Karmakar S.P., Paton A.W., Paton J.C., Abdin M.Z.,
RA   Basu A., Kalia M., Vrati S.;
RT   "GRP78 Is an Important Host Factor for Japanese Encephalitis Virus Entry
RT   and Replication in Mammalian Cells.";
RL   J. Virol. 91:0-0(2017).
RN   [55]
RP   FUNCTION.
RX   PubMed=29719251; DOI=10.1016/j.celrep.2018.03.122;
RA   Hassdenteufel S., Johnson N., Paton A.W., Paton J.C., High S.,
RA   Zimmermann R.;
RT   "Chaperone-Mediated Sec61 Channel Gating during ER Import of Small
RT   Precursor Proteins Overcomes Sec61 Inhibitor-Reinforced Energy Barrier.";
RL   Cell Rep. 23:1373-1386(2018).
RN   [56]
RP   SUBCELLULAR LOCATION.
RX   PubMed=29497057; DOI=10.1038/s41467-018-03355-0;
RA   Bai M., Vozdek R., Hnizda A., Jiang C., Wang B., Kuchar L., Li T.,
RA   Zhang Y., Wood C., Feng L., Dang Y., Ma D.K.;
RT   "Conserved roles of C. elegans and human MANFs in sulfatide binding and
RT   cytoprotection.";
RL   Nat. Commun. 9:897-897(2018).
RN   [57]
RP   FUNCTION (MICROBIAL INFECTION), INTERACTION WITH R.DELEMAR COTH3 (MICROBIAL
RP   INFECTION), AND INDUCTION.
RX   PubMed=32487760; DOI=10.1128/mbio.01087-20;
RA   Alqarihi A., Gebremariam T., Gu Y., Swidergall M., Alkhazraji S.,
RA   Soliman S.S.M., Bruno V.M., Edwards J.E. Jr., Filler S.G., Uppuluri P.,
RA   Ibrahim A.S.;
RT   "GRP78 and Integrins Play Different Roles in Host Cell Invasion during
RT   Mucormycosis.";
RL   MBio 11:e01087-e01087(2020).
RN   [58]
RP   FUNCTION (MICROBIAL INFECTION), INTERACTION WITH ZIKA VIRUS ENVELOPE
RP   PROTEIN E (MICROBIAL INFECTION), AND SUBCELLULAR LOCATION.
RX   PubMed=33432092; DOI=10.1038/s41598-020-79803-z;
RA   Khongwichit S., Sornjai W., Jitobaom K., Greenwood M., Greenwood M.P.,
RA   Hitakarun A., Wikan N., Murphy D., Smith D.R.;
RT   "A functional interaction between GRP78 and Zika virus E protein.";
RL   Sci. Rep. 11:393-393(2021).
RN   [59]
RP   FUNCTION, INTERACTION WITH ERN1 AND EIF2AK3, AND INDUCTION.
RX   PubMed=36739529; DOI=10.1016/j.celrep.2023.112066;
RA   Kovaleva V., Yu L.Y., Ivanova L., Shpironok O., Nam J., Eesmaa A.,
RA   Kumpula E.P., Sakson S., Toots U., Ustav M., Huiskonen J.T.,
RA   Voutilainen M.H., Lindholm P., Karelson M., Saarma M.;
RT   "MANF regulates neuronal survival and UPR through its ER-located receptor
RT   IRE1alpha.";
RL   Cell Rep. 42:112066-112066(2023).
RN   [60]
RP   INTERACTION WITH ZIKA VIRUS ENVELOPE PROTEIN E (MICROBIAL INFECTION),
RP   INTERACTION WITH ZIKA VIRUS NON-STRUCTURAL PROTEIN 1 (MICROBIAL INFECTION),
RP   AND MUTAGENESIS OF ARG-492 AND THR-518.
RX   PubMed=38710792; DOI=10.1038/s41598-024-61195-z;
RA   Sornjai W., Promma P., Priewkhiew S., Ramphan S., Jaratsittisin J.,
RA   Jinagool P., Wikan N., Greenwood M., Murphy D., Smith D.R.;
RT   "The interaction of GRP78 and Zika virus E and NS1 proteins occurs in a
RT   chaperone-client manner.";
RL   Sci. Rep. 14:10407-10407(2024).
RN   [61]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 26-410.
RX   PubMed=20072699; DOI=10.1371/journal.pone.0008625;
RA   Wisniewska M., Karlberg T., Lehtio L., Johansson I., Kotenyova T.,
RA   Moche M., Schuler H.;
RT   "Crystal structures of the ATPase domains of four human Hsp70 isoforms:
RT   HSPA1L/Hsp70-hom, HSPA2/Hsp70-2, HSPA6/Hsp70B', and HSPA5/BiP/GRP78.";
RL   PLoS ONE 5:E8625-E8625(2010).
RN   [62]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 26-407 IN COMPLEXES WITH ATP
RP   ANALOG.
RX   PubMed=21526763; DOI=10.1021/jm101625x;
RA   Macias A.T., Williamson D.S., Allen N., Borgognoni J., Clay A., Daniels Z.,
RA   Dokurno P., Drysdale M.J., Francis G.L., Graham C.J., Howes R.,
RA   Matassova N., Murray J.B., Parsons R., Shaw T., Surgenor A.E., Terry L.,
RA   Wang Y., Wood M., Massey A.J.;
RT   "Adenosine-derived inhibitors of 78 kDa glucose regulated protein (Grp78)
RT   ATPase: insights into isoform selectivity.";
RL   J. Med. Chem. 54:4034-4041(2011).
RN   [63] {ECO:0007744|PDB:5E84, ECO:0007744|PDB:5E85, ECO:0007744|PDB:5E86}
RP   X-RAY CRYSTALLOGRAPHY (2.57 ANGSTROMS) OF 418-637 IN COMPLEX WITH ATP,
RP   CATALYTIC ACTIVITY, ACTIVITY REGULATION, AND MUTAGENESIS OF THR-229.
RX   PubMed=26655470; DOI=10.1016/j.str.2015.10.012;
RA   Yang J., Nune M., Zong Y., Zhou L., Liu Q.;
RT   "Close and allosteric opening of the polypeptide-binding site in a human
RT   Hsp70 chaperone BiP.";
RL   Structure 23:2191-2203(2015).
CC   -!- FUNCTION: Endoplasmic reticulum chaperone that plays a key role in
CC       protein folding and quality control in the endoplasmic reticulum lumen
CC       (PubMed:2294010, PubMed:23769672, PubMed:23990668, PubMed:28332555).
CC       Involved in the correct folding of proteins and degradation of
CC       misfolded proteins via its interaction with DNAJC10/ERdj5, probably to
CC       facilitate the release of DNAJC10/ERdj5 from its substrate (By
CC       similarity). Acts as a key repressor of the EIF2AK3/PERK and ERN1/IRE1-
CC       mediated unfolded protein response (UPR) (PubMed:11907036,
CC       PubMed:1550958, PubMed:19538957, PubMed:36739529). In the unstressed
CC       endoplasmic reticulum, recruited by DNAJB9/ERdj4 to the luminal region
CC       of ERN1/IRE1, leading to disrupt the dimerization of ERN1/IRE1, thereby
CC       inactivating ERN1/IRE1 (By similarity). Also binds and inactivates
CC       EIF2AK3/PERK in unstressed cells (PubMed:11907036). Accumulation of
CC       misfolded protein in the endoplasmic reticulum causes release of
CC       HSPA5/BiP from ERN1/IRE1 and EIF2AK3/PERK, allowing their
CC       homodimerization and subsequent activation (PubMed:11907036). Plays an
CC       auxiliary role in post-translational transport of small presecretory
CC       proteins across endoplasmic reticulum (ER). May function as an
CC       allosteric modulator for SEC61 channel-forming translocon complex,
CC       likely cooperating with SEC62 to enable the productive insertion of
CC       these precursors into SEC61 channel. Appears to specifically regulate
CC       translocation of precursors having inhibitory residues in their mature
CC       region that weaken channel gating. May also play a role in apoptosis
CC       and cell proliferation (PubMed:26045166).
CC       {ECO:0000250|UniProtKB:G3I8R9, ECO:0000250|UniProtKB:P20029,
CC       ECO:0000269|PubMed:11907036, ECO:0000269|PubMed:1550958,
CC       ECO:0000269|PubMed:19538957, ECO:0000269|PubMed:2294010,
CC       ECO:0000269|PubMed:23769672, ECO:0000269|PubMed:23990668,
CC       ECO:0000269|PubMed:26045166, ECO:0000269|PubMed:28332555,
CC       ECO:0000269|PubMed:29719251, ECO:0000269|PubMed:36739529}.
CC   -!- FUNCTION: (Microbial infection) Plays an important role in viral
CC       binding to the host cell membrane and entry for several flaviruses such
CC       as Dengue virus, Zika virus and Japanese encephalitis virus
CC       (PubMed:15098107, PubMed:28053106, PubMed:33432092). Acts as a
CC       component of the cellular receptor for Dengue virus serotype 2/DENV-2
CC       on human liver cells (PubMed:15098107). {ECO:0000269|PubMed:15098107,
CC       ECO:0000269|PubMed:28053106, ECO:0000269|PubMed:33432092}.
CC   -!- FUNCTION: (Microbial infection) Acts as a receptor for CotH proteins
CC       expressed by fungi of the order mucorales, the causative agent of
CC       mucormycosis, which plays an important role in epithelial cell invasion
CC       by the fungi (PubMed:20484814, PubMed:24355926, PubMed:32487760). Acts
CC       as a receptor for R.delemar CotH3 in nasal epithelial cells, which may
CC       be an early step in rhinoorbital/cerebral mucormycosis (RCM) disease
CC       progression (PubMed:32487760). {ECO:0000269|PubMed:20484814,
CC       ECO:0000269|PubMed:24355926, ECO:0000269|PubMed:32487760}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.10;
CC         Evidence={ECO:0000269|PubMed:26655470};
CC   -!- ACTIVITY REGULATION: The chaperone activity is regulated by ATP-induced
CC       allosteric coupling of the nucleotide-binding (NBD) and substrate-
CC       binding (SBD) domains. In the ADP-bound and nucleotide-free (apo)
CC       states, the two domains have little interaction (PubMed:26655470). In
CC       contrast, in the ATP-bound state the two domains are tightly coupled,
CC       which results in drastically accelerated kinetics in both binding and
CC       release of polypeptide substrates (PubMed:26655470). J domain-
CC       containing co-chaperones (DNAJB9/ERdj4 or DNAJC10/ERdj5) stimulate the
CC       ATPase activity and are required for efficient substrate recognition by
CC       HSPA5/BiP (By similarity). Homooligomerization inactivates
CC       participating HSPA5/BiP protomers and probably act as reservoirs to
CC       store HSPA5/BiP molecules when they are not needed by the cell (By
CC       similarity). {ECO:0000250|UniProtKB:G3I8R9,
CC       ECO:0000269|PubMed:26655470, ECO:0000303|PubMed:28286085}.
CC   -!- SUBUNIT: Monomer and homooligomer; homooligomerization via the
CC       interdomain linker inactivates the chaperone activity and acts as a
CC       storage of HSPA5/BiP molecules (By similarity). Interacts with DNAJC1
CC       (via J domain) (By similarity). Component of an EIF2 complex at least
CC       composed of CELF1/CUGBP1, CALR, CALR3, EIF2S1, EIF2S2, HSP90B1 and
CC       HSPA5 (By similarity). Part of a large chaperone multiprotein complex
CC       comprising DNAJB11, HSP90B1, HSPA5, HYOU, PDIA2, PDIA4, PDIA6, PPIB,
CC       SDF2L1, UGGT1 and very small amounts of ERP29, but not, or at very low
CC       levels, CALR nor CANX (By similarity). Interacts with TMEM132A and
CC       TRIM21 (PubMed:12699405). May form a complex with ERLEC1, OS9, SEL1L
CC       and SYVN1 (PubMed:18264092, PubMed:18502753). Interacts with DNAJC10
CC       (PubMed:12411443, PubMed:23769672). Interacts with DNAJB9/ERdj4;
CC       leading to recruit HSPA5/BiP to ERN1/IRE1 (By similarity). Interacts
CC       with ERN1/IRE1 (via luminal domain); the interaction takes place
CC       following interaction with DNAJB9/ERdj4 and leads to inactivate
CC       ERN1/IRE1, the interaction also competitively inhibits ERN1 interaction
CC       with MANF (PubMed:36739529). Interacts directly with MANF (via SAP
CC       domain); the interaction inhibits ATP binding to HSPA5/BiP and
CC       subsequent nucleotide exchange (By similarity). Interacts with
CC       EIF2AK3/PERK (via luminal domain); interaction leads to inactivate
CC       EIF2AK3/PERK (PubMed:11907036, PubMed:36739529). Interacts with MX1 (By
CC       similarity). Interacts with METTL23 (PubMed:23349634). Interacts with
CC       CEMIP; the interaction induces calcium leakage from the endoplasmic
CC       reticulum and cell migration (PubMed:23990668). Interacts with PCSK4
CC       form; the interaction takes place in the endoplasmic reticulum
CC       (PubMed:21080038). Interacts with CIPC (PubMed:26657846). Interacts
CC       with CCDC88B (via C-terminus); the interaction opposes ERN1-mediated
CC       JNK activation, protecting against apoptosis (PubMed:21289099).
CC       Interacts with INPP5K; necessary for INPP5K localization at the
CC       endoplasmic reticulum (PubMed:26940976). Interacts with MANF; the
CC       interaction is direct (PubMed:22637475). Interacts with LOXL2; leading
CC       to activate the ERN1/IRE1-XBP1 pathway of the unfolded protein response
CC       (PubMed:28332555). Interacts with CLU under stressed condition;
CC       interaction increases CLU protein stability; facilitates its
CC       retrotranslocation and redistribution to the mitochondria;
CC       cooperatively suppress stress-induced apoptosis by stabilizing
CC       mitochondrial membrane integrity (PubMed:22689054). Interacts with
CC       CCDC47 (By similarity). Interacts with CLN3 (Probable). Interacts with
CC       ELAPOR1; may regulate the function of HSPA5 in apoptosis and cell
CC       proliferation (PubMed:26045166). Interacts with CASP7
CC       (PubMed:26045166). Interacts with ILDR2; the interaction stabilizes
CC       ILDR2 expression (By similarity). Interacts with ADAM7 (By similarity).
CC       {ECO:0000250|UniProtKB:G3I8R9, ECO:0000250|UniProtKB:P20029,
CC       ECO:0000269|PubMed:11907036, ECO:0000269|PubMed:12411443,
CC       ECO:0000269|PubMed:12699405, ECO:0000269|PubMed:18264092,
CC       ECO:0000269|PubMed:18502753, ECO:0000269|PubMed:21080038,
CC       ECO:0000269|PubMed:21289099, ECO:0000269|PubMed:22637475,
CC       ECO:0000269|PubMed:22689054, ECO:0000269|PubMed:23349634,
CC       ECO:0000269|PubMed:23769672, ECO:0000269|PubMed:23990668,
CC       ECO:0000269|PubMed:26045166, ECO:0000269|PubMed:26657846,
CC       ECO:0000269|PubMed:26940976, ECO:0000269|PubMed:28332555,
CC       ECO:0000269|PubMed:36739529, ECO:0000305|PubMed:18621045}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Japanese encephalitis
CC       virus envelope protein E. {ECO:0000269|PubMed:28053106}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with R.delemar invasin CotH3
CC       on the surface of nasal epithelial cells (PubMed:24355926,
CC       PubMed:32487760). Interacts with R.delemar invasin CotH2
CC       (PubMed:24355926). {ECO:0000269|PubMed:24355926,
CC       ECO:0000269|PubMed:32487760}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Zika virus envelope
CC       protein E and non-structural protein 1 in a chaperone-client manner.
CC       {ECO:0000269|PubMed:33432092, ECO:0000269|PubMed:38710792}.
CC   -!- INTERACTION:
CC       P11021; Q9BYF1: ACE2; NbExp=6; IntAct=EBI-354921, EBI-7730807;
CC       P11021; P05067: APP; NbExp=6; IntAct=EBI-354921, EBI-77613;
CC       P11021; P18850: ATF6; NbExp=2; IntAct=EBI-354921, EBI-852157;
CC       P11021; Q9ULD4-2: BRPF3; NbExp=3; IntAct=EBI-354921, EBI-23662416;
CC       P11021; Q6E0U4: DMKN; NbExp=3; IntAct=EBI-354921, EBI-7943171;
CC       P11021; Q9UBS4: DNAJB11; NbExp=5; IntAct=EBI-354921, EBI-713113;
CC       P11021; Q9UBS3: DNAJB9; NbExp=2; IntAct=EBI-354921, EBI-713124;
CC       P11021; P49184: DNASE1L1; NbExp=3; IntAct=EBI-354921, EBI-20894690;
CC       P11021; Q92874: DNASE1L2; NbExp=3; IntAct=EBI-354921, EBI-1751995;
CC       P11021; Q9NZJ5: EIF2AK3; NbExp=4; IntAct=EBI-354921, EBI-766076;
CC       P11021; P04626: ERBB2; NbExp=3; IntAct=EBI-354921, EBI-641062;
CC       P11021; O75460: ERN1; NbExp=3; IntAct=EBI-354921, EBI-371750;
CC       P11021; O75460-1: ERN1; NbExp=4; IntAct=EBI-354921, EBI-15600828;
CC       P11021; P62993: GRB2; NbExp=4; IntAct=EBI-354921, EBI-401755;
CC       P11021; Q15486: GUSBP1; NbExp=3; IntAct=EBI-354921, EBI-712457;
CC       P11021; P14625: HSP90B1; NbExp=2; IntAct=EBI-354921, EBI-359129;
CC       P11021; Q9Y4L1: HYOU1; NbExp=3; IntAct=EBI-354921, EBI-1054186;
CC       P11021; P01721: IGLV6-57; NbExp=3; IntAct=EBI-354921, EBI-54607224;
CC       P11021; O95868: LY6G6D; NbExp=2; IntAct=EBI-354921, EBI-12382527;
CC       P11021; Q15691: MAPRE1; NbExp=4; IntAct=EBI-354921, EBI-1004115;
CC       P11021; Q9Y2H9: MAST1; NbExp=2; IntAct=EBI-354921, EBI-3385920;
CC       P11021; Q9Y328: NSG2; NbExp=2; IntAct=EBI-354921, EBI-7101695;
CC       P11021; Q96IZ0: PAWR; NbExp=8; IntAct=EBI-354921, EBI-595869;
CC       P11021; Q15084: PDIA6; NbExp=2; IntAct=EBI-354921, EBI-1043087;
CC       P11021; P04049: RAF1; NbExp=5; IntAct=EBI-354921, EBI-365996;
CC       P11021; P61619: SEC61A1; NbExp=3; IntAct=EBI-354921, EBI-358919;
CC       P11021; P36955: SERPINF1; NbExp=3; IntAct=EBI-354921, EBI-2932733;
CC       P11021; Q9H173: SIL1; NbExp=10; IntAct=EBI-354921, EBI-2840325;
CC       P11021; Q9UHI5: SLC7A8; NbExp=3; IntAct=EBI-354921, EBI-13292283;
CC       P11021; Q13573: SNW1; NbExp=5; IntAct=EBI-354921, EBI-632715;
CC       P11021; Q6URK8: SPMIP8; NbExp=2; IntAct=EBI-354921, EBI-53990332;
CC       P11021; Q6PF05: TTC23L; NbExp=3; IntAct=EBI-354921, EBI-8656864;
CC       P11021; Q13404: UBE2V1; NbExp=3; IntAct=EBI-354921, EBI-1050671;
CC       P11021; Q9NYU1: UGGT2; NbExp=2; IntAct=EBI-354921, EBI-1054215;
CC       P11021; P08670: VIM; NbExp=3; IntAct=EBI-354921, EBI-353844;
CC       P11021; P09544: WNT2; NbExp=2; IntAct=EBI-354921, EBI-3905552;
CC       P11021; Q6T424; NbExp=3; IntAct=EBI-354921, EBI-7888150;
CC       P11021; Q9QXT0: Cnpy2; Xeno; NbExp=2; IntAct=EBI-354921, EBI-8321111;
CC       P11021; Q91YW3: Dnajc3; Xeno; NbExp=2; IntAct=EBI-354921, EBI-8381770;
CC       P11021; Q9Z2B5: Eif2ak3; Xeno; NbExp=2; IntAct=EBI-354921, EBI-1226344;
CC       P11021; Q62627: Pawr; Xeno; NbExp=4; IntAct=EBI-354921, EBI-1187240;
CC       P11021; K0BRG7: S; Xeno; NbExp=9; IntAct=EBI-354921, EBI-16040613;
CC       P11021; P0DTC2: S; Xeno; NbExp=8; IntAct=EBI-354921, EBI-25474821;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen
CC       {ECO:0000269|PubMed:21080038, ECO:0000269|PubMed:21289099,
CC       ECO:0000269|PubMed:23990668, ECO:0000269|PubMed:29497057}. Melanosome
CC       {ECO:0000269|PubMed:12643545}. Cytoplasm
CC       {ECO:0000250|UniProtKB:P20029}. Cell surface
CC       {ECO:0000269|PubMed:15098107, ECO:0000269|PubMed:20484814,
CC       ECO:0000269|PubMed:24355926, ECO:0000269|PubMed:27159390,
CC       ECO:0000269|PubMed:28053106, ECO:0000269|PubMed:33432092}.
CC       Note=Identified by mass spectrometry in melanosome fractions from stage
CC       I to stage IV (PubMed:12643545). Localizes to the cell surface of
CC       epithelial cells in response to high levels of free iron
CC       (PubMed:20484814, PubMed:24355926, PubMed:27159390).
CC       {ECO:0000269|PubMed:12643545, ECO:0000269|PubMed:20484814,
CC       ECO:0000269|PubMed:24355926, ECO:0000269|PubMed:27159390}.
CC   -!- INDUCTION: By endoplasmic reticulum stress (PubMed:21289099,
CC       PubMed:36739529). Induced in nasal epithelial cells by high free iron
CC       levels (PubMed:20484814, PubMed:27159390, PubMed:32487760). Induced in
CC       nasal epithelial cells in high glucose (PubMed:20484814,
CC       PubMed:27159390, PubMed:32487760). Induced in nasal epithelial cells by
CC       3-hydroxybutyric acid (BHB) (PubMed:27159390, PubMed:32487760).
CC       {ECO:0000269|PubMed:20484814, ECO:0000269|PubMed:21289099,
CC       ECO:0000269|PubMed:27159390, ECO:0000269|PubMed:32487760,
CC       ECO:0000269|PubMed:36739529}.
CC   -!- DOMAIN: The interdomain linker regulates the chaperone activity by
CC       mediating the formation of homooligomers. Homooligomers are formed by
CC       engagement of the interdomain linker of one HSPA5/BiP molecule as a
CC       typical substrate of an adjacent HSPA5/BiP molecule. HSPA5/BiP
CC       oligomerization inactivates participating HSPA5/BiP protomers.
CC       HSPA5/BiP oligomers probably act as reservoirs to store HSPA5/BiP
CC       molecules when they are not needed by the cell. When the levels of
CC       unfolded proteins rise, cells can rapidly break up these oligomers to
CC       make active monomers. {ECO:0000250|UniProtKB:G3I8R9}.
CC   -!- PTM: AMPylated by FICD (PubMed:25601083). In unstressed cells,
CC       AMPylation at Thr-518 by FICD inactivates the chaperome activity:
CC       AMPylated form is locked in a relatively inert state and only weakly
CC       stimulated by J domain-containing proteins (By similarity). In response
CC       to endoplasmic reticulum stress, de-AMPylation by the same protein,
CC       FICD, restores the chaperone activity (By similarity).
CC       {ECO:0000250|UniProtKB:G3I8R9, ECO:0000269|PubMed:25601083}.
CC   -!- DISEASE: Note=Autoantigen in rheumatoid arthritis.
CC       {ECO:0000269|PubMed:11160188}.
CC   -!- BIOTECHNOLOGY: Antibodies against the protein protects endothelial
CC       cells from invasion by the fungus R.delemar, a causative agent of
CC       mucormycosis, and could thus potentially be used to treat mucormycosis
CC       disease (PubMed:20484814). Antibodies against the protein also protect
CC       a diabetic ketoacidosis mouse model against mucormycosis
CC       (PubMed:20484814). {ECO:0000269|PubMed:20484814}.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family. {ECO:0000305}.
CC   -!- CAUTION: AMPylation was initially reported to take place at Ser-365 and
CC       Thr-366 in vitro, and promote activation of HSPA5/BiP
CC       (PubMed:25601083). However, it was later shown that AMPylation takes
CC       place at Thr-518 and leads to inactivation of HSPA5/BiP.
CC       {ECO:0000250|UniProtKB:G3I8R9, ECO:0000269|PubMed:25601083}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/40876/HSPA5";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M19645; AAA52614.1; -; Genomic_DNA.
DR   EMBL; X87949; CAA61201.1; -; mRNA.
DR   EMBL; AJ271729; CAB71335.1; -; mRNA.
DR   EMBL; AF216292; AAF42836.1; -; mRNA.
DR   EMBL; DQ385847; ABD04090.1; -; Genomic_DNA.
DR   EMBL; AL354710; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471090; EAW87620.1; -; Genomic_DNA.
DR   EMBL; BC020235; AAH20235.1; -; mRNA.
DR   EMBL; X59969; CAA42595.1; -; Genomic_DNA.
DR   EMBL; AF188611; AAF13605.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS6863.1; -.
DR   PIR; A29821; A29821.
DR   RefSeq; NP_005338.1; NM_005347.5.
DR   PDB; 3IUC; X-ray; 2.40 A; A/C=26-410.
DR   PDB; 3LDL; X-ray; 2.30 A; A/B=26-407.
DR   PDB; 3LDN; X-ray; 2.20 A; A/B=26-407.
DR   PDB; 3LDO; X-ray; 1.95 A; A/B=26-407.
DR   PDB; 3LDP; X-ray; 2.20 A; A/B=26-407.
DR   PDB; 5E84; X-ray; 2.99 A; A/B/C/D/E/F=25-633.
DR   PDB; 5E85; X-ray; 2.57 A; A=418-637.
DR   PDB; 5E86; X-ray; 2.68 A; A=418-637.
DR   PDB; 5EVZ; X-ray; 1.85 A; A/B=26-407.
DR   PDB; 5EX5; X-ray; 1.90 A; A/B=26-407.
DR   PDB; 5EXW; X-ray; 1.90 A; A/B=26-407.
DR   PDB; 5EY4; X-ray; 1.86 A; A/B=26-407.
DR   PDB; 5F0X; X-ray; 1.60 A; A/B=26-407.
DR   PDB; 5F1X; X-ray; 1.90 A; A/B=26-407.
DR   PDB; 5F2R; X-ray; 2.15 A; A/B=26-407.
DR   PDB; 6ASY; X-ray; 1.85 A; A/B=25-633.
DR   PDB; 6CZ1; X-ray; 1.68 A; A/B=26-407.
DR   PDB; 6DFM; X-ray; 2.14 A; A/B=26-407.
DR   PDB; 6DFO; X-ray; 2.54 A; A/B=26-407.
DR   PDB; 6DO2; X-ray; 1.70 A; A/B=26-407.
DR   PDB; 6DWS; X-ray; 1.90 A; A/B=26-407.
DR   PDB; 6ZMD; X-ray; 2.64 A; A=28-549.
DR   PDB; 7N1R; X-ray; 2.03 A; A/B=25-633.
DR   PDBsum; 3IUC; -.
DR   PDBsum; 3LDL; -.
DR   PDBsum; 3LDN; -.
DR   PDBsum; 3LDO; -.
DR   PDBsum; 3LDP; -.
DR   PDBsum; 5E84; -.
DR   PDBsum; 5E85; -.
DR   PDBsum; 5E86; -.
DR   PDBsum; 5EVZ; -.
DR   PDBsum; 5EX5; -.
DR   PDBsum; 5EXW; -.
DR   PDBsum; 5EY4; -.
DR   PDBsum; 5F0X; -.
DR   PDBsum; 5F1X; -.
DR   PDBsum; 5F2R; -.
DR   PDBsum; 6ASY; -.
DR   PDBsum; 6CZ1; -.
DR   PDBsum; 6DFM; -.
DR   PDBsum; 6DFO; -.
DR   PDBsum; 6DO2; -.
DR   PDBsum; 6DWS; -.
DR   PDBsum; 6ZMD; -.
DR   PDBsum; 7N1R; -.
DR   AlphaFoldDB; P11021; -.
DR   EMDB; EMD-19600; -.
DR   EMDB; EMD-19601; -.
DR   SASBDB; P11021; -.
DR   SMR; P11021; -.
DR   BioGRID; 109541; 1756.
DR   CORUM; P11021; -.
DR   DIP; DIP-33189N; -.
DR   ELM; P11021; -.
DR   FunCoup; P11021; 3895.
DR   IntAct; P11021; 757.
DR   MINT; P11021; -.
DR   STRING; 9606.ENSP00000324173; -.
DR   BindingDB; P11021; -.
DR   ChEMBL; CHEMBL1781865; -.
DR   DrugBank; DB00945; Acetylsalicylic acid.
DR   DrugBank; DB00025; Antihemophilic factor, human recombinant.
DR   DrugBank; DB09130; Copper.
DR   DrugBank; DB13998; Lonoctocog alfa.
DR   DrugBank; DB13999; Moroctocog alfa.
DR   DrugCentral; P11021; -.
DR   TCDB; 1.A.33.1.5; the cation channel-forming heat shock protein-70 (hsp70) family.
DR   GlyCosmos; P11021; 1 site, 1 glycan.
DR   GlyGen; P11021; 10 sites, 2 O-linked glycans (8 sites).
DR   iPTMnet; P11021; -.
DR   MetOSite; P11021; -.
DR   PhosphoSitePlus; P11021; -.
DR   SwissPalm; P11021; -.
DR   BioMuta; HSPA5; -.
DR   DMDM; 14916999; -.
DR   OGP; P11021; -.
DR   REPRODUCTION-2DPAGE; P11021; -.
DR   CPTAC; CPTAC-524; -.
DR   CPTAC; CPTAC-525; -.
DR   CPTAC; non-CPTAC-2616; -.
DR   jPOST; P11021; -.
DR   MassIVE; P11021; -.
DR   PaxDb; 9606-ENSP00000324173; -.
DR   PeptideAtlas; P11021; -.
DR   PRIDE; P11021; -.
DR   ProteomicsDB; 52688; -.
DR   Pumba; P11021; -.
DR   TopDownProteomics; P11021; -.
DR   ABCD; P11021; 16 sequenced antibodies.
DR   Antibodypedia; 3926; 1741 antibodies from 50 providers.
DR   DNASU; 3309; -.
DR   Ensembl; ENST00000324460.7; ENSP00000324173.6; ENSG00000044574.10.
DR   GeneID; 3309; -.
DR   KEGG; hsa:3309; -.
DR   MANE-Select; ENST00000324460.7; ENSP00000324173.6; NM_005347.5; NP_005338.1.
DR   AGR; HGNC:5238; -.
DR   CIViC; 3309; 1 evidence item across 1 molecular profile.
DR   ClinPGx; PA29504; -.
DR   CTD; 3309; -.
DR   DisGeNET; 3309; -.
DR   GeneCards; HSPA5; -.
DR   HGNC; HGNC:5238; HSPA5.
DR   HPA; ENSG00000044574; Low tissue specificity.
DR   MIM; 138120; gene.
DR   OpenTargets; ENSG00000044574; -.
DR   VEuPathDB; HostDB:ENSG00000044574; -.
DR   eggNOG; KOG0100; Eukaryota.
DR   GeneTree; ENSGT00940000154787; -.
DR   HOGENOM; CLU_005965_3_0_1; -.
DR   InParanoid; P11021; -.
DR   OMA; VQRDIKH; -.
DR   OrthoDB; 2401965at2759; -.
DR   PAN-GO; P11021; 16 GO annotations based on evolutionary models.
DR   PhylomeDB; P11021; -.
DR   PathwayCommons; P11021; -.
DR   Reactome; R-HSA-114608; Platelet degranulation.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-HSA-381033; ATF6 (ATF6-alpha) activates chaperones.
DR   Reactome; R-HSA-381042; PERK regulates gene expression.
DR   Reactome; R-HSA-381070; IRE1alpha activates chaperones.
DR   Reactome; R-HSA-381183; ATF6 (ATF6-alpha) activates chaperone genes.
DR   Reactome; R-HSA-8874177; ATF6B (ATF6-beta) activates chaperones.
DR   Reactome; R-HSA-983170; Antigen Presentation: Folding, assembly and peptide loading of class I MHC.
DR   Reactome; R-HSA-9909505; Modulation of host responses by IFN-stimulated genes.
DR   SignaLink; P11021; -.
DR   SIGNOR; P11021; -.
DR   Agora; ENSG00000044574; -.
DR   BioGRID-ORCS; 3309; 703 hits in 1167 CRISPR screens.
DR   CD-CODE; 232F8A39; P-body.
DR   CD-CODE; 91857CE7; Nucleolus.
DR   CD-CODE; B5B9A610; PML body.
DR   CD-CODE; BEB5E62D; Anisosome.
DR   CD-CODE; DEE660B4; Stress granule.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; HSPA5; human.
DR   EvolutionaryTrace; P11021; -.
DR   GeneWiki; Binding_immunoglobulin_protein; -.
DR   GenomeRNAi; 3309; -.
DR   Pharos; P11021; Tchem.
DR   PRO; PR:P11021; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; P11021; protein.
DR   Bgee; ENSG00000044574; Expressed in vena cava and 214 other cell types or tissues.
DR   ExpressionAtlas; P11021; baseline and differential.
DR   GO; GO:0009986; C:cell surface; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:MGI.
DR   GO; GO:0034663; C:endoplasmic reticulum chaperone complex; IDA:UniProtKB.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:BHF-UCL.
DR   GO; GO:0005793; C:endoplasmic reticulum-Golgi intermediate compartment; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0030496; C:midbody; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IMP:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IDA:AgBase.
DR   GO; GO:0140662; F:ATP-dependent protein folding chaperone; IEA:InterPro.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0005509; F:calcium ion binding; TAS:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0031072; F:heat shock protein binding; IBA:GO_Central.
DR   GO; GO:0051787; F:misfolded protein binding; IDA:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0044183; F:protein folding chaperone; IBA:GO_Central.
DR   GO; GO:0140311; F:protein sequestering activity; IDA:UniProt.
DR   GO; GO:0030291; F:protein serine/threonine kinase inhibitor activity; IDA:UniProtKB.
DR   GO; GO:0051087; F:protein-folding chaperone binding; TAS:BHF-UCL.
DR   GO; GO:0043022; F:ribosome binding; IEA:Ensembl.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0051082; F:unfolded protein binding; TAS:UniProtKB.
DR   GO; GO:0042149; P:cellular response to glucose starvation; IDA:UniProtKB.
DR   GO; GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl.
DR   GO; GO:0021680; P:cerebellar Purkinje cell layer development; IEA:Ensembl.
DR   GO; GO:0021589; P:cerebellum structural organization; IEA:Ensembl.
DR   GO; GO:0030968; P:endoplasmic reticulum unfolded protein response; IBA:GO_Central.
DR   GO; GO:0006983; P:ER overload response; IEA:Ensembl.
DR   GO; GO:0036503; P:ERAD pathway; IBA:GO_Central.
DR   GO; GO:0036498; P:IRE1-mediated unfolded protein response; IEA:Ensembl.
DR   GO; GO:0035437; P:maintenance of protein localization in endoplasmic reticulum; IMP:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:1903895; P:negative regulation of IRE1-mediated unfolded protein response; ISS:UniProtKB.
DR   GO; GO:1903898; P:negative regulation of PERK-mediated unfolded protein response; IDA:UniProtKB.
DR   GO; GO:0031333; P:negative regulation of protein-containing complex assembly; ISS:UniProtKB.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0031204; P:post-translational protein targeting to membrane, translocation; IMP:UniProtKB.
DR   GO; GO:0034975; P:protein folding in endoplasmic reticulum; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0042026; P:protein refolding; IBA:GO_Central.
DR   GO; GO:1903891; P:regulation of ATF6-mediated unfolded protein response; TAS:ParkinsonsUK-UCL.
DR   GO; GO:1903894; P:regulation of IRE1-mediated unfolded protein response; IDA:UniProt.
DR   GO; GO:1903897; P:regulation of PERK-mediated unfolded protein response; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0060904; P:regulation of protein folding in endoplasmic reticulum; TAS:BHF-UCL.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0021762; P:substantia nigra development; HEP:UniProtKB.
DR   CDD; cd10241; ASKHA_NBD_HSP70_BiP; 1.
DR   DisProt; DP01938; -.
DR   FunFam; 3.30.420.40:FF:000720; Endoplasmic reticulum chaperone BiP; 1.
DR   FunFam; 3.90.640.10:FF:000153; Endoplasmic reticulum chaperone BiP; 1.
DR   FunFam; 2.60.34.10:FF:000002; Heat shock 70 kDa; 1.
DR   FunFam; 3.30.30.30:FF:000001; heat shock 70 kDa protein-like; 1.
DR   FunFam; 1.20.1270.10:FF:000061; Heat shock protein family A (Hsp70) member 5; 1.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 3.30.420.40; -; 2.
DR   Gene3D; 3.90.640.10; Actin, Chain A, domain 4; 1.
DR   Gene3D; 2.60.34.10; Substrate Binding Domain Of DNAk, Chain A, domain 1; 1.
DR   InterPro; IPR043129; ATPase_NBD.
DR   InterPro; IPR042050; BIP_NBD.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   NCBIfam; NF001413; PRK00290.1; 1.
DR   PANTHER; PTHR19375; HEAT SHOCK PROTEIN 70KDA; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF53067; Actin-like ATPase domain; 2.
DR   SUPFAM; SSF100934; Heat shock protein 70kD (HSP70), C-terminal subdomain; 1.
DR   SUPFAM; SSF100920; Heat shock protein 70kD (HSP70), peptide-binding domain; 1.
DR   PROSITE; PS00014; ER_TARGET; 1.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Chaperone; Cytoplasm;
KW   Direct protein sequencing; Endoplasmic reticulum; Host-virus interaction;
KW   Hydrolase; Isopeptide bond; Methylation; Nitration; Nucleotide-binding;
KW   Phosphoprotein; Proteomics identification; Reference proteome; Signal;
KW   Ubl conjugation.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000269|PubMed:2294010,
FT                   ECO:0000269|PubMed:9150948"
FT   CHAIN           19..654
FT                   /note="Endoplasmic reticulum chaperone BiP"
FT                   /id="PRO_0000013566"
FT   REGION          1..80
FT                   /note="Required for interaction with ELAPOR1"
FT                   /evidence="ECO:0000269|PubMed:26045166"
FT   REGION          125..280
FT                   /note="Nucleotide-binding (NBD)"
FT                   /evidence="ECO:0000303|PubMed:28286085"
FT   REGION          409..419
FT                   /note="Interdomain linker"
FT                   /evidence="ECO:0000250|UniProtKB:G3I8R9"
FT   REGION          420..500
FT                   /note="Substrate-binding (SBD)"
FT                   /evidence="ECO:0000303|PubMed:28286085"
FT   REGION          633..654
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           651..654
FT                   /note="Prevents secretion from ER"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        644..654
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         36..39
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:21526763"
FT   BINDING         96
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:21526763"
FT   BINDING         227..229
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:21526763"
FT   BINDING         293..300
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:21526763"
FT   BINDING         364..367
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:21526763"
FT   MOD_RES         86
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06761"
FT   MOD_RES         125
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P20029"
FT   MOD_RES         160
FT                   /note="3'-nitrotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P20029"
FT   MOD_RES         213
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P20029"
FT   MOD_RES         271
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P0DMV8"
FT   MOD_RES         326
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P20029"
FT   MOD_RES         353
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P20029"
FT   MOD_RES         447
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P20029"
FT   MOD_RES         492
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P0DMV8"
FT   MOD_RES         518
FT                   /note="O-AMP-threonine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:G3I8R9"
FT   MOD_RES         518
FT                   /note="Phosphothreonine; alternate"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         585
FT                   /note="N6,N6,N6-trimethyllysine; by METTL21A; in vitro"
FT                   /evidence="ECO:0000269|PubMed:23349634,
FT                   ECO:0000269|PubMed:23921388, ECO:0007744|PubMed:24129315"
FT   MOD_RES         585
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         585
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         591
FT                   /note="N6-methyllysine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         643
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P20029"
FT   MOD_RES         648
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P20029"
FT   CROSSLNK        352
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25114211,
FT                   ECO:0007744|PubMed:25218447, ECO:0007744|PubMed:25755297,
FT                   ECO:0007744|PubMed:28112733"
FT   CROSSLNK        353
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0007744|PubMed:25114211"
FT   VARIANT         543
FT                   /note="N -> H (in dbSNP:rs35356639)"
FT                   /evidence="ECO:0000269|Ref.5"
FT                   /id="VAR_025815"
FT   MUTAGEN         229
FT                   /note="T->A: Impaired ATPase activity."
FT                   /evidence="ECO:0000269|PubMed:26655470"
FT   MUTAGEN         492
FT                   /note="R->E: Significantly reduced binding to ZIKVE and NS1
FT                   proteins."
FT                   /evidence="ECO:0000269|PubMed:38710792"
FT   MUTAGEN         518
FT                   /note="T->A: Significantly reduced binding to ZIKVE and NS1
FT                   proteins."
FT                   /evidence="ECO:0000269|PubMed:38710792"
FT   MUTAGEN         585
FT                   /note="K->R: Complete loss of in vitro methylation by
FT                   METTL21A."
FT                   /evidence="ECO:0000269|PubMed:23349634,
FT                   ECO:0000269|PubMed:23921388"
FT   CONFLICT        297
FT                   /note="Missing (in Ref. 1; AAA52614 and 2; CAA61201)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        418
FT                   /note="D -> H (in Ref. 1; AAA52614 and 2; CAA61201)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        439
FT                   /note="R -> S (in Ref. 1; AAA52614 and 2; CAA61201)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        447
FT                   /note="K -> N (in Ref. 1; AAA52614 and 2; CAA61201)"
FT                   /evidence="ECO:0000305"
FT   STRAND          31..34
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   STRAND          37..45
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   STRAND          47..52
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   STRAND          60..63
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   STRAND          66..68
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   STRAND          74..76
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   HELIX           78..82
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   HELIX           84..86
FT                   /evidence="ECO:0007829|PDB:6ASY"
FT   HELIX           88..90
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   STRAND          91..93
FT                   /evidence="ECO:0007829|PDB:6ASY"
FT   HELIX           95..97
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   TURN            98..100
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   HELIX           106..114
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   STRAND          116..122
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   STRAND          125..131
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   STRAND          137..140
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   HELIX           142..161
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   STRAND          167..172
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   HELIX           178..190
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   STRAND          194..200
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   HELIX           201..208
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   TURN            209..212
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   STRAND          215..225
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   STRAND          230..238
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   STRAND          241..250
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   HELIX           255..274
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   HELIX           278..280
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   HELIX           282..298
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   TURN            299..301
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   STRAND          302..313
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   STRAND          316..323
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   HELIX           324..337
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   HELIX           339..348
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   HELIX           353..355
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   STRAND          358..363
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   HELIX           364..367
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   HELIX           369..378
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   TURN            379..381
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   TURN            390..392
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   HELIX           393..405
FT                   /evidence="ECO:0007829|PDB:5F0X"
FT   STRAND          415..419
FT                   /evidence="ECO:0007829|PDB:6ASY"
FT   STRAND          424..428
FT                   /evidence="ECO:0007829|PDB:6ASY"
FT   TURN            429..431
FT                   /evidence="ECO:0007829|PDB:5E85"
FT   STRAND          433..437
FT                   /evidence="ECO:0007829|PDB:6ASY"
FT   STRAND          442..451
FT                   /evidence="ECO:0007829|PDB:6ASY"
FT   STRAND          461..468
FT                   /evidence="ECO:0007829|PDB:6ASY"
FT   HELIX           473..475
FT                   /evidence="ECO:0007829|PDB:6ASY"
FT   STRAND          476..484
FT                   /evidence="ECO:0007829|PDB:6ASY"
FT   STRAND          491..493
FT                   /evidence="ECO:0007829|PDB:6ASY"
FT   STRAND          497..503
FT                   /evidence="ECO:0007829|PDB:6ASY"
FT   STRAND          509..515
FT                   /evidence="ECO:0007829|PDB:6ASY"
FT   TURN            516..518
FT                   /evidence="ECO:0007829|PDB:6ASY"
FT   STRAND          524..526
FT                   /evidence="ECO:0007829|PDB:7N1R"
FT   TURN            529..531
FT                   /evidence="ECO:0007829|PDB:7N1R"
FT   HELIX           535..576
FT                   /evidence="ECO:0007829|PDB:6ASY"
FT   TURN            579..581
FT                   /evidence="ECO:0007829|PDB:6ASY"
FT   HELIX           582..585
FT                   /evidence="ECO:0007829|PDB:6ASY"
FT   HELIX           588..607
FT                   /evidence="ECO:0007829|PDB:6ASY"
FT   HELIX           613..631
FT                   /evidence="ECO:0007829|PDB:6ASY"
SQ   SEQUENCE   654 AA;  72333 MW;  59B7D8D85BC32A00 CRC64;
     MKLSLVAAML LLLSAARAEE EDKKEDVGTV VGIDLGTTYS CVGVFKNGRV EIIANDQGNR
     ITPSYVAFTP EGERLIGDAA KNQLTSNPEN TVFDAKRLIG RTWNDPSVQQ DIKFLPFKVV
     EKKTKPYIQV DIGGGQTKTF APEEISAMVL TKMKETAEAY LGKKVTHAVV TVPAYFNDAQ
     RQATKDAGTI AGLNVMRIIN EPTAAAIAYG LDKREGEKNI LVFDLGGGTF DVSLLTIDNG
     VFEVVATNGD THLGGEDFDQ RVMEHFIKLY KKKTGKDVRK DNRAVQKLRR EVEKAKRALS
     SQHQARIEIE SFYEGEDFSE TLTRAKFEEL NMDLFRSTMK PVQKVLEDSD LKKSDIDEIV
     LVGGSTRIPK IQQLVKEFFN GKEPSRGINP DEAVAYGAAV QAGVLSGDQD TGDLVLLDVC
     PLTLGIETVG GVMTKLIPRN TVVPTKKSQI FSTASDNQPT VTIKVYEGER PLTKDNHLLG
     TFDLTGIPPA PRGVPQIEVT FEIDVNGILR VTAEDKGTGN KNKITITNDQ NRLTPEEIER
     MVNDAEKFAE EDKKLKERID TRNELESYAY SLKNQIGDKE KLGGKLSSED KETMEKAVEE
     KIEWLESHQD ADIEDFKAKK KELEEIVQPI ISKLYGSAGP PPTGEEDTAE KDEL
//
